Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples